ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,099Medicare Part D Prescriptions Filled, Including Refills

Rank: 160 out of 2116

$612K Total Retail Price of All Prescriptions

Rank: 396 out of 2116

484 Patients Receiving at Least One Drug in Part D
60% Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New Jersey
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

14% of this provider’s 484 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 484 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $77 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LISINOPRIL 649 471 107 1 7
SIMVASTATIN 578 404 97 2 2
OMEPRAZOLE 555 323 99 3 5
METFORMIN HCL 522 379 89 4 8
ATORVASTATIN CALCIUM 331 265 64 5 3
METOPROLOL TARTRATE 328 249 59 6 10
ZOLPIDEM TARTRATE 317 147 53 7 17
HYDROCHLOROTHIAZIDE 297 185 56 8 13
AMLODIPINE BESYLATE 276 205 52 9 1
FUROSEMIDE 252 166 54 10 6
LEVOTHYROXINE SODIUM 244 142 40 11 4
PRAVASTATIN SODIUM 227 163 45 12 19
PROAIR HFA 211 130 46 13 44
CHLORTHALIDONE 197 159 32 14 163
HYDROCODONE-ACETAMINOPHEN 185 120 36 S3 15 51
CARVEDILOL 160 146 28 16 21
ALLOPURINOL 151 115 25 17 48
MONTELUKAST SODIUM 148 95 25 18 40
TRAMADOL HCL 144 76 44 19 30
TAMSULOSIN HCL 143 104 29 20 27
LANTUS 136 115 22 21 79
METOPROLOL SUCCINATE 136 65 25 21 9
FLUTICASONE PROPIONATE 130 78 32 23 43
ADVAIR DISKUS 125 68 23 24 41
CLOPIDOGREL 122 105 20 25 12
ALENDRONATE SODIUM 122 83 33 25 39
OXYCODONE-ACETAMINOPHEN 122 51 32 S2 25 47
LANTUS SOLOSTAR 112 80 23 28 70
ALPRAZOLAM 107 58 21 B 29 14
VENTOLIN HFA 106 60 41 30 144
PANTOPRAZOLE SODIUM 102 84 22 31 29
GABAPENTIN 101 54 25 32 23
DIOVAN 101 71 20 32 16
IBUPROFEN 95 37 28 34 74
WARFARIN SODIUM 91 35 15 35 11
CLONAZEPAM 87 61 21 B 36 57
ENDOCET 87 41 19 S2 36 152
ATENOLOL 85 60 13 38 26
SYMBICORT 80 60 13 39 132
GLIPIZIDE 76 58 11 40 84
COLCRYS 74 45 15 41 195
SPIRIVA 70 54 13 42 65
CYCLOBENZAPRINE HCL 68 11 18 R 43 121
OXYCODONE HCL-ACETAMINOPHEN 66 27 21 S2 44 93
OXYCODONE HCL 66 <11 12 S2 44 61
LOVAZA 66 37 11 44 52
MIRTAZAPINE 64 59* 16 47 45
HYDROCORTISONE 64 47 23 47 263
NEXIUM 64 <11 <11 47 20
ENALAPRIL MALEATE 63 <11 <11 50 32
LOSARTAN POTASSIUM 63 42 12 50 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 28 12 52 54
GLIMEPIRIDE 58 38 11 53 34
LORAZEPAM 58 <11 <11 B 53 38
GLIPIZIDE XL 58 <11 <11 53 126
FLOVENT HFA 57 <11 <11 56 232
OXYCONTIN 56 <11 <11 S2 57 101
SERTRALINE HCL 55 38 15 58 28
ISOSORBIDE MONONITRATE ER 55 55 11 58 63
LYRICA 51 26 15 60 75
HYDROXYZINE PAMOATE 50 29 18 R 61 354
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.